Ani Pharmaceuticals (ANIP) Asset Utilization Ratio (2011 - 2026)

Ani Pharmaceuticals has disclosed Asset Utilization Ratio across 16 years of filings, most recently posting 0.65 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.65, up 23.37% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.65 (up 23.37% YoY), and the FY2025 annual result was 0.65, up 15.5% from the prior year.
• Asset Utilization Ratio came in at 0.65 for Q1 2026 at Ani Pharmaceuticals, up from 0.62 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.65 in Q1 2026 to a low of 0.3 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.51 (2023), against an average of 0.5.
• Across the five-year window, Asset Utilization Ratio slipped 18.83% in 2022 and jumped 57.73% in 2023, its largest moves.
• Ani Pharmaceuticals' Asset Utilization Ratio stood at 0.42 in 2022, then grew by 28.56% to 0.54 in 2023, then decreased by 11.95% to 0.48 in 2024, then advanced by 29.82% to 0.62 in 2025, then rose by 4.06% to 0.65 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.65 (Q1 2026), 0.62 (Q4 2025), and 0.6 (Q3 2025), per Business Quant data.